| Authors: |
Gammage PA; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. payam.gammage@mrc-mbu.cam.ac.uk., Viscomi C; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Simard ML; Max Planck Institute for Biology of Ageing, Cologne, Germany., Costa ASH; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Gaude E; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Powell CA; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Van Haute L; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., McCann BJ; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Rebelo-Guiomar P; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.; Graduate Program in Areas of Basic and Applied Biology (GABBA), University of Porto, Porto, Portugal., Cerutti R; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Zhang L; Sangamo Therapeutics Inc., Richmond, CA, USA., Rebar EJ; Sangamo Therapeutics Inc., Richmond, CA, USA., Zeviani M; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Frezza C; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Stewart JB; Max Planck Institute for Biology of Ageing, Cologne, Germany., Minczuk M; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. michal.minczuk@mrc-mbu.cam.ac.uk. |
